← back to search

Thomas Fuerst

Friedrich-Alexander-Universität Erlangen-Nürnberg · DE
Area of research
Orthopedics and Sports Medicine · Physiology
Research interest
Research interests include Medicine, Osteoporosis, Quantitative computed tomography, Teriparatide, Sclerostin, and Internal medicine.
h-index
citations
447
works
4
NIH funding
primary concept
email

Recent publications

Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass
Journal of Bone and Mineral Research 2016cited by 140position: middledoi
Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength
Journal of Bone and Mineral Research 2014cited by 69position: middledoi
Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial
The Journal of Clinical Endocrinology & Metabolism 2013cited by 122position: middledoi
Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab
Journal of Bone and Mineral Research 2013cited by 116position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Klaus Engelke · Friedrich-Alexander-Universität Erlangen-Nürnberg4 papers (2013–2016)Cesar Libanati · Amgen (United States)2 papers (2013–2016) · 2 papers (2013–2014)Angela M. Cheung · University Health Network2 papers (2013–2014)Jacques P. Brown · Université Laval2 papers (2013–2016) · 2 papers (2013–2014)Harry K. Genant · University of California, San Francisco2 papers (2013–2016)Chris Recknor · Amgen (United States)2 papers (2013–2016)Tony M. Keaveny · University of California, Berkeley2 papers (2013–2013) · 2 papers (2013–2014)Stefan Goemaere · Lund University2 papers (2013–2016) · 2 papers (2013–2014) · 2 papers (2013–2014)Elizabeth Rosenberg · The University of Texas Southwestern Medical Center2 papers (2013–2014)Roland Chapurlat · Université Claude Bernard Lyon 11 papers (2014–2014) · 1 papers (2016–2016)Andreas Grauer · Amgen (United States)1 papers (2016–2016)David L. Kendler · University of British Columbia1 papers (2013–2013) · 1 papers (2013–2013)Michael R. McClung · Bone Health and Osteoporosis Foundation1 papers (2013–2013)